Challenging powerhouse Pfizer, BridgeBio's launch of Attruby is off to a 'great start,' analyst says
BridgeBio reported that 1,028 unique prescriptions have been written by 516 different healthcare professionals in the U.S. for Attruby, the company's rare disease drug which was launched on Dec. 11. Analysts at Evercore ISI said that the launch "is off to a great start."
BridgeBio reported that 1,028 unique prescriptions have been written by 516 different healthcare professionals in the U.S. for Attruby, the company's rare disease drug which was launched on Dec. 11. Analysts at Evercore ISI said that the launch "is off to a great start."
